We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Sustained delivery devices are transforming the ...
Chugai Pharmaceutical Co., Ltd. announced that the results of a phase I/II study (TEIEN study) in Japan to evaluate the efficacy and safety of Port Delivery System with Ranibizumab (PDS), in patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback